Hall Capital Management Reduces Stake in Thermo Fisher Scientific

Institutional investor cuts holdings in medical research company by over 67%

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Hall Capital Management Co. Inc. reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 67.4% in the 3rd quarter, according to the company's recent disclosure with the Securities and Exchange Commission. The firm now owns 1,592 shares of the medical research company's stock, valued at $772,000.

Why it matters

Thermo Fisher Scientific is a major player in the medical research and instrumentation industry. Changes in institutional ownership of the company's stock can provide insight into broader market trends and investor sentiment around the firm.

The details

According to the filing, Hall Capital Management sold 3,297 shares of Thermo Fisher Scientific during the third quarter, reducing its total holdings to 1,592 shares. The firm cited portfolio rebalancing as the reason for the reduced stake in the medical research company.

  • Hall Capital Management filed the disclosure with the SEC in the 3rd quarter of 2026.

The players

Hall Capital Management Co. Inc.

An institutional investment firm that reduced its stake in Thermo Fisher Scientific by over 67% in the 3rd quarter.

Thermo Fisher Scientific Inc.

A global provider of scientific instrumentation, reagents, software, and services that support research, clinical, and industrial laboratories.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the shifting investment strategies of institutional investors and the evolving landscape of the medical research industry. The reduced stake in Thermo Fisher Scientific by Hall Capital Management may signal broader market trends that investors will want to monitor.